Mass. Ruling Doesn't End NJ Eyedrops Case, 3rd Circ. Told
A potential class of eyedrops users alleging generic-drug makers such as Sandoz Inc. boosted prescription sales by using bottles that dispensed larger-than-needed drops told the Third Circuit Wednesday that a suit...To view the full article, register now.
Already a subscriber? Click here to view full article